Role of Biomarkers in Acute Coronary Syndrome
Author Information
Author(s): Nagesh C.M. Roy, Ambuj
Primary Institution: All India Institute of Medical Sciences, New Delhi, India
Hypothesis
The study explores the role of established and emerging biomarkers in the diagnosis and prognosis of acute coronary syndrome (ACS).
Conclusion
Biomarkers like troponin, BNP, and CRP are crucial in diagnosing and predicting outcomes in ACS, and newer biomarkers may enhance this further.
Supporting Evidence
- Troponin is a well-established biomarker for diagnosing and predicting outcomes in ACS.
- BNP and NT-proBNP levels are associated with increased risk of heart failure and death in ACS patients.
- C-reactive protein levels correlate with the extent of atherosclerosis and predict coronary events.
Takeaway
Doctors use special markers in the blood to see if someone has heart problems. New markers might help them do an even better job.
Methodology
The review discusses various established and emerging biomarkers and their roles in ACS management.
Limitations
The review highlights the need for clinical trials to test the effectiveness and cost-effectiveness of multimarker testing.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website